Literature DB >> 23077688

Successful treatment of anal carcinoma with Paclitaxel, Cisplatin, and radiotherapy in a patient who developed a coronary syndrome from 5-fu.

Shalini Garg1, Ross A Abrams, William T Leslie.   

Abstract

Entities:  

Year:  2012        PMID： 23077688      PMCID： PMC3433263     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  11 in total

1.  [A case of effective weekly paclitaxel administration for advanced gastric cancer].

Authors:  Yasuhiro Hasegawa; Fusakuni Kuroda; Takashi Doi; Shinichi Takemura; Hiroyuki Nakamura
Journal:  Gan To Kagaku Ryoho       Date:  2011-04

2.  [Weekly paclitaxel therapy leading to complete disappearance of multiple liver metastases and subsequent surgical resection for advanced gastric cancer].

Authors:  Yasuyuki Jin; Kimiatsu Hasuo; Kazuhito Tsuchida; Sho Sawazaki; Shigeya Hayashi; Yasushi Rino; Munetaka Masuda
Journal:  Gan To Kagaku Ryoho       Date:  2011-04

3.  Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study.

Authors:  J A Martenson; S R Lipsitz; M Lefkopoulou; P F Engstrom; Y Y Dayal; C D Cobau; M M Oken; D G Haller
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

4.  Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.

Authors:  Nobuyuki Yamamoto; Kazuhiko Nakagawa; Yasumasa Nishimura; Kayoko Tsujino; Miyako Satouchi; Shinzoh Kudo; Toyoaki Hida; Masaaki Kawahara; Koji Takeda; Nobuyuki Katakami; Toshiyuki Sawa; Soichiro Yokota; Takashi Seto; Fumio Imamura; Hideo Saka; Yasuo Iwamoto; Hiroshi Semba; Yasutaka Chiba; Hisao Uejima; Masahiro Fukuoka
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

5.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

6.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

7.  [Five cases of advanced gastroesophageal junction adenocarcinoma successfully treated with chemoradiotherapy followed by curative resection].

Authors:  Masanori Takahashi; Keisuke Koeda; Hisataka Fujiwara; Takehiro Chiba; Akira Sasaki; Go Wakabayashi
Journal:  Gan To Kagaku Ryoho       Date:  2010-11

8.  Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314.

Authors:  B Sischy; R L Doggett; J M Krall; D G Taylor; W T Sause; J A Lipsett; H G Seydel
Journal:  J Natl Cancer Inst       Date:  1989-06-07       Impact factor: 13.506

9.  Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Authors:  Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher Willett
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

10.  Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal.

Authors:  N D Nigro; H G Seydel; B Considine; V K Vaitkevicius; L Leichman; J J Kinzie
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.